Marian Yvette Williams-Brown

Marian Yvette Williams-Brown

Auto-generated profile, based on publicly available information

Marian Yvette Williams-Brown

Dell Medical School, Austin, TX 78712, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2011 in The Journal of Steroid Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
MWMarian Y. Williams-Brown
Marian Y. Williams-Brown
SSSana M. Salih
Sana M. Salih
XXXia Xu
Xia Xu
TVTimothy D. Veenstra
Timothy D. Veenstra
MSMuhammad Saeed
Muhammad Saeed
SSSalama A. Salama
Salama A. Salama

1 April 2024 in Journal of Clinical Oncology
Verified
Journal Article
Open access
CHChae Young Han
Chae Young Han
KLKaren H. Lu
Karen H. Lu
GCGwen Corrigan
Gwen Corrigan
APAlexandra Perez
Alexandra Perez
SKSharlene D. Kohring
Sharlene D. Kohring
Robert BastRobert Bast
Robert Bast
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, for which the primary end point has already been reported. PURPOSE: The Normal Risk Ovarian Screening Study (NROSS) tested a two-stage screening strategy in postmenopausal women at conventional hereditary risk where significantly rising cancer antigen (CA)-125 prompted transvaginal sonography (TVS) and abnormal TVS prompted surgery to detect ovarian cancer. METHODS: A total of 7,856 healthy postmenopausal women were screened annually for a total of 50,596 woman-years in a single-arm study (ClinicalTrials.gov identifier: NCT00539162 ). Serum CA125 was analyzed with the Risk of Ovarian Cancer Algorithm (ROCA) each year. If risk was unchanged and <1:2,000, women returned in a year. If risk increased above 1:500, TVS was undertaken immediately, and if risk was intermediate, CA125 was repeated in 3 months with a further increase in risk above 1:500 prompting referral for TVS. An average of 2% of participants were referred to TVS annually. RESULTS: Thirty-four patients were referred for operations detecting 15 ovarian cancers and two borderline tumors with 12 in early stage (I-II). In addition, seven endometrial cancers were detected with six in stage I. As four ovarian cancers and two borderline tumors were diagnosed with a normal ROCA, the sensitivity for detecting ovarian and borderline cancer was 74% (17 of 23), and 70% of ROCA-detected cases (12 of 17) were in stage I-II. NROSS screening reduced late-stage (III-IV) disease by 34% compared with UKCTOCS controls and by 30% compared with US SEER values. The positive predictive value (PPV) was 50% (17 of 34) for detecting ovarian cancer and 74% (25 of 34) for any cancer, far exceeding the minimum acceptable study end point of 10% PPV. CONCLUSION: While the NROSS trial was not powered to detect reduced mortality, the high specificity, PPV, and marked stage shift support further development of this strategy.

8 February 2022 in JMIR Cancer
Verified
Journal Article
Open access
YZYan Zhang
Yan Zhang
SYSiqi Yi
Siqi Yi
CTCiaran B Trace
Ciaran B Trace
MWMarian Yvette Williams-Brown
Marian Yvette Williams-Brown
Background: Experts in gynecological cancer care recommend that all patients with invasive or high-grade ovarian cancer (OC) undergo genetic testing. However, even patients who intend to take or have taken genetic tests have many unaddressed information needs regarding genetic testing. Existing genetic counseling falls short of adequately addressing this challenge. Objective: This study aims to investigate the genetic testing–related information needs of patients with OC to inform the design of interactive technology-based interventions that can enhance communication of genetic testing information to patients. Methods: We interviewed 20 patients with OC who had taken genetic tests and gathered genetic testing–related messages from an active OC web-based community. The interview transcripts and web-based community messages were analyzed using the qualitative content analysis method. Results: Data analyses produced a comprehensive taxonomy of the genetic testing–related information needs of patients with OC, which included five major topic clusters: knowledge of genetic testing as a medical test, genetic testing process, genetic testing implications for patients, implications for family members, and medical terminology. Findings indicated that patients wanted to receive information that was relevant, understandable, concise, usable, appropriate, sympathetic, and available when needed. They also preferred various channels to receive information, including internet-based technologies, print, and conversations with health care providers. Conclusions: Patients with OC need a range of information to address the uncertainties and challenges that they encounter while taking genetic tests. Their preferences for channels to receive information vary widely. A multichannel information delivery solution that combines both provider-led and peer-to-peer education models is needed to supplement existing genetic counseling to effectively meet the genetic testing–related information needs of patients with OC.

1 March 2017 in Gynecologic Oncology
Verified
Journal Article
Closed access
YCYiwen Cui
Yiwen Cui
HSHaleh Sangi-Haghpeykar
Haleh Sangi-Haghpeykar
BPBruce Patsner
Bruce Patsner
JBJennifer M.M. Bump
Jennifer M.M. Bump
MWMarian Y. Williams-Brown
Marian Y. Williams-Brown
MAMatthew L. Linley Anderson
Matthew L. Linley Anderson

3 November 2023 in Gynecologic Oncology
Verified
Journal Article
Closed access
RSRebekah Summey
Rebekah Summey
MBMichelle Benoit
Michelle Benoit
MWM. Yvette Williams-Brown
M. Yvette Williams-Brown

24 September 2024 in Journal of Medical Robotics Research
Verified
Journal Article
Closed access
AHAndres Hassun
Andres Hassun
KKKimberly Kho
Kimberly Kho
MWM. Yvette Williams-Brown
M. Yvette Williams-Brown
Ann Majewicz FeyAnn Majewicz Fey
Ann Majewicz Fey